Here are 18 key notes on orthopedic and spine device companies over the past week.
Amedica is set to release its Valeo II C interbody fusion device system.
BONESUPPORT appointed Richard Davies as its new CEO, effective immediately.
BionX Medical Technologies completed a Series E funding round.
Episurf Medical's Epioscopy Damage Assessment Tool receives CE Mark.
Johnson & Johnson's orthopedics sales are down in the fourth quarter and full year of 2015.
A few nonspecific comments about acquisitions by Johnson & Johnson CEO and Chairman Alex Gorsky, boosted TransEnterix's stock.
LDR made a minority investment in Poly-Shape, a French manufacturing company specializing in laser sintering.
A Minnesota appeals court revived the Medtronic shareholders' lawsuit against the company's merger with Covidien.
Nextremity Solutions finalized a strategic alliance with BEPSA.
Paradigm Spine released data that reveals the long-term sustained therapeutic effect of coflex Interlaminar Stabilization for lumbar spinal stenosis patients, compared to fusion.
Polyganics received FDA clearance for its device that decreases neuroma formation.
The Orthopaedic Implant Company has launched its Intramedullary Hip Nail System.
SpineFrontier appointed Jerry Goldstein, a leader in the MRI industry, to its board of directors.
SpineGuard named Steve McAdoo vice president of business development.
Stryker CFO William Jellison announced during the fourth quarter earnings conference call that the company will build a new 3-D printed product manufacturing facility this year.
Stryker Vice President and CFO William R. Jellison will retire from his post after three years with the company.
Stryker reported strong organic net sales in 2015 as well as a net sales increase in the fourth quarter.
VertiFlex raised $26.8 million in funding.